Valuation Ipca Laboratories Limited

Stocks

Market Closed - NSE India S.E. Other stock markets 12:05:08 07/08/2026 BST			5-day change	1st Jan Change
1,735.80 ^INR	+0.09%		-1.31%	+22.33%

06-26	Ipca Laboratories Limited agreed to acquire remaining 50.35% stake in Krebs Biochemicals & Industries Limited for INR 612 million.	CI
06-01	Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	270,385	205,589	313,934	381,038	406,231	440,380	-	-
Change	-	-23.96%	52.7%	21.38%	6.61%	8.41%	-	-
Enterprise Value (EV) ¹	275,070	201,870	325,349	391,231	408,673	428,556	416,720	409,549
Change	-	-26.61%	61.17%	20.25%	4.46%	4.87%	-2.76%	-1.72%
P/E	30.6x	43.6x	57.4x	51.6x	35.6x	31.6x	26.5x	22.6x
PBR	4.92x	2.58x	4.96x	5.48x	5.04x	4.68x	4.04x	3.39x
PEG	-	-0.9x	3.6x	1.5x	0.7x	1.4x	1.4x	1.3x
Capitalization / Revenue	4.64x	3.29x	4.07x	4.26x	4.21x	4.09x	3.67x	3.31x
EV / Revenue	4.72x	3.23x	4.22x	4.38x	4.24x	3.98x	3.47x	3.08x
EV / EBITDA	21x	21.8x	24.6x	22.7x	20.7x	18.2x	15.3x	13.1x
EV / EBIT	25.6x	30.3x	33.8x	29.5x	26.2x	22.6x	19x	16x
EV / FCF	72.9x	64.8x	60.9x	71.7x	83.5x	45.2x	37.9x	28x
FCF Yield	1.37%	1.54%	1.64%	1.4%	1.2%	2.21%	2.64%	3.57%
Dividend per Share ²	8	4	4	2	6	5.792	6.258	6.25
Rate of return	0.75%	0.49%	0.32%	0.13%	0.37%	0.33%	0.36%	0.36%
EPS ²	34.85	18.58	21.57	29.08	44.98	54.99	65.61	76.72
Distribution rate	23%	21.5%	18.5%	6.88%	13.3%	10.5%	9.54%	8.15%
Net sales ¹	58,298	62,443	77,050	89,396	96,463	107,687	120,078	132,985
EBITDA ¹	13,073	9,268	13,212	17,261	19,786	23,560	27,251	31,158
EBIT ¹	10,748	6,652	9,639	13,283	15,604	18,921	21,987	25,600
Net income ¹	8,841	4,713	5,474	7,377	11,411	14,000	16,697	19,470
Net Debt ¹	4,685	-3,720	11,415	10,193	2,442	-11,824	-23,660	-30,831
Reference price ²	1,065.75	810.35	1,237.40	1,501.90	1,601.20	1,735.80	1,735.80	1,735.80
Nbr of stocks (in thousands)	253,704	253,704	253,704	253,704	253,704	253,704	-	-
Announcement Date	24/05/22	29/05/23	29/05/24	29/05/25	29/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPCA LABORATORIES LIMITED	31.53x	3.98x	18.17x	0.33%	4.62B
ELI LILLY AND COMPANY	33.78x	12.37x	24.91x	0.57%	1,062B
JOHNSON & JOHNSON	28.59x	-	-	2.09%	619B
ABBVIE INC.	32.06x	7.3x	15.18x	2.84%	431B
ROCHE HOLDING AG	20.32x	4.82x	11.94x	2.74%	358B
NOVARTIS AG	21.87x	5.66x	14.12x	2.84%	293B
ASTRAZENECA PLC	20.44x	4.22x	11.99x	2.09%	247B
AMGEN INC.	25.38x	6.71x	11.89x	2.49%	219B
NOVO NORDISK A/S	13.28x	4.8x	10.09x	3.83%	200B
GILEAD SCIENCES, INC.	-40.65x	5.84x	32.95x	2.52%	162B
Average	18.66x	6.19x	16.81x	2.23%	359.69B
Weighted average by Cap.	24.44x	8.10x	18.28x	1.99%